Hunan Cancer Hospital
Central China's provincial cancer hospital, a high-enrolling trial site in lung and gastrointestinal cancer with a large radiotherapy department.
Hunan Cancer Hospital was founded in 1972 and is the affiliated cancer hospital of Central South University's Xiangya School of Medicine. It is one of the most active Chinese sites for registration trials of domestic PD-1 antibodies, EGFR and ALK inhibitors and ADCs, and has particular strength in lung cancer, gastric and colorectal cancer, head and neck surgery and gynaecological radiotherapy. The hospital operates the Hunan cancer registry and a phase 1 clinical trial centre, and participates in the national cancer screening programmes for rural China.
- Lung cancer trials
- Gastrointestinal oncology
- Radiotherapy
- Phase 1 centre
Pages like this
not linked directly; found by shared links- InstitutionTaipei Veterans General Hospital
Shares Gastric & gastro-oesophageal junction cancer, Immune checkpoint inhibitors, Colorectal cancer, Non-small-cell lung cancer.
- PersonFeng Wang
Shares Gastric & gastro-oesophageal junction cancer, Immune checkpoint inhibitors, Colorectal cancer.
- InstitutionZhejiang Cancer Hospital
Shares IMRT / IGRT (modern external beam), Cervical cancer, Immune checkpoint inhibitors, Non-small-cell lung cancer.
- InstitutionHenan Cancer Hospital
Shares Gastric & gastro-oesophageal junction cancer, Immune checkpoint inhibitors, Non-small-cell lung cancer.
- InstitutionWest Japan Oncology Group
Shares Small-molecule kinase inhibitors, Gastric & gastro-oesophageal junction cancer, Immune checkpoint inhibitors, Colorectal cancer.
- InstitutionVietnam National Cancer Hospital (K Hospital)
Shares IMRT / IGRT (modern external beam), Cervical cancer, Gastric & gastro-oesophageal junction cancer, Non-small-cell lung cancer.
- TrialPACIFIC
Shares IMRT / IGRT (modern external beam), Immune checkpoint inhibitors, Non-small-cell lung cancer.
- InstitutionAuckland City Hospital / Te Pūriri o Te Ora Cancer and Blood Service
Shares Small-molecule kinase inhibitors, Colorectal cancer, Non-small-cell lung cancer.